Treatment

Daplusiran/Tomligisiran Dose Level 1 clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE2
A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)
This study is testing new medicines, daplusiran/tomligisiran (DAP/TOM) and bepirovirsen, for people with long-term Hepatitis B. It aims to find the best dose of DAP/TOM to use with bepirovirsen to improve treatment.
For: Chronic Hepatitis B Virus Infection · Hepatitis B
United States · Australia · Belgium